No claim interpretation summersaults for the EPO (T 2027/23) By Dr Rose Hughes at Monday, September 01, 2025 claim interpretation description amendments G 1/24 G1/24 G1/25 PatKat +
Divergence between the UPC and EPO on claim interpretation and description definitions (Agfa v Gucci, UPC_CFI_278/2023) By Dr Rose Hughes at Monday, August 11, 2025 claim interpretation description amendments G 1/24 G1/24 patents PatKat Rose Hughes upc +
G 1/24 in the spotlight: Description definitions do not override clear claim language (T 1999/23) By Dr Rose Hughes at Thursday, July 24, 2025 claim interpretation epo G 1/24 patents PatKat Rose Hughes +
Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy By Dr Rose Hughes at Tuesday, May 27, 2025 antibody inventions epo event report G 1/24 G 2/21 patents PatKat pharma patents plausibility Rose Hughes upc +
No back-pedaling on prosecution disclaimers (Azurity v. Alkem, Fed. Cir. Case No. 23-1977) By Dr Rose Hughes at Tuesday, April 22, 2025 formulation patents G 1/24 ip strategy patents PatKat Rose Hughes us patents +
[GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings By Dr Rose Hughes at Friday, March 28, 2025 adaptation of description Boards of Appeal claim interpretation description amendments Enlarged Board of Appeal epo G 1/24 Guest post patents PatKat +